JAPAN ATOMIC INDUSTRIAL FORUM, INC.

for Japanese

30 July, 2019

QST President Says New System Will Reinforce R&D on Charged Particle Therapy

On June 20, President Toshio Hirano and other representatives from Japan’s National Institute for Quantum and Radiological Science and Technology (QST) met the press to explain the FY19 reorganization of the organization into “QST 2.0,” with research on quantum life science at its core.

QST President Toshio Hirano (center)

The institute was created in April 2016 through the partial merger of its predecessor, the National Institute of Radiological Sciences (NIRS), together with the Quantum Beam Directorate and the Nuclear Fusion Directorate of the Japan Atomic Energy Agency (JAEA).

On the occasion of entering its fourth year, QST is carrying out the major structural reorganization, aiming to reinforce its R&D efforts using its next-generation charged-particle cancer therapy device, known as the quantum scalpel. It will also continue to develop human resources to work in radiation emergency medicine.

The Quantum Life Science Directorate, a new organization directly under President Hirano, will take a nationwide approach, developing organic linkages among several research bases and cross-appointing researchers from various universities to realize QST’s goals: to clarify life phenomena based on quantum theory and technology, and to promote medical development.

Expecting the new research area of quantum medical science to span “from scholarly research to innovation,” QST’s approach and commitment is to extensively return its research results to society.

Placed under the newly-established Quantum Medical Science Directorate are the National Institute of Radiological Sciences (NIRS), the Center for Advanced Radiation Emergency Medicine and the QST Hospital. In cooperation with other directorates, the NIRS, an R&D institution, will especially focus on developing the quantum scalpel, which integrates superconductivity and laser technologies, to realize a society with “no cancer deaths and healthier longevity.”

The QST Hospital, redesigned since the NIRS took it over, promotes the clinical application of research results. An International Therapy Research Center will also be newly established to accept foreign trainees in the area of charged-particle cancer therapy.

At the June 20 press conference, Managing Director Takashi Nakano of the Quantum Medical Science Directorate stressed that charged-particle cancer therapy would never be able to come into wide use with equipment at its current size.

It has been a quarter century since the Heavy Ion Medical Accelerator in Chiba (HIMAC)—the pioneering device for charged-particle cancer therapy—was first used in treatment. Nakano explained the beginnings of R&D on the quantum scalpel, which is about one-fortieth the size of HIMAC, as well as its future outlook.

Meanwhile, the equipment at Gunma University is already one-third the size of that used at HIMAC. Given, however, the expense of constructing a special building to house it, the goal is to create a device—nearing the stage in which a prototype is feasible—that can be installed in existing medical facilities.

Also at the same press conference, Toshikazu Yamashita, director of the Center for Advanced Radiation Emergency Medicine, talked about his organization’s activities. In addition to his center, he said that four similar centers have been designated by the Nuclear Regulation Authority (NRA) at the following institutions around Japan: Hirosaki University, Fukushima Medical University, Hiroshima University, and Nagasaki University.

Among the five, the NRA has designated the one located at QST as the key site, making it responsible for playing a central, guiding role. Yamashita added, though, that all five bases would cooperate with each other to build a nationwide system.

Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

SNS facebooktwitter

NPPs Map

Video

“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)

8 July, 2019
“The current situation at Fukushima Daiichi NPS” -From 3.11 toward the future- (ver, July 2019)09:17

Recent News

23 January, 2020
Finishing Mission in Japan, IAEA’s IRRS Points Out Importance of NRA’s Communicating with Nuclear Industry
21 January, 2020
Evacuation Orders for Futaba, Okuma, Tomioka Towns to Be Partially Lifted in March, with JR Joban Line to Be Completely Reopened for Service
16 January, 2020
Japan’s Nuclear Power Plant Capacity Factor Stood at Just 21.4 Percent Last Year
26 December, 2019
IEEJ’s Supply-Demand Outlook for FY2020 Looks at Effect of Specific Safety Facility Installation Deadlines
25 December, 2019
ANRE Committee Clarifies Options for Treated Contaminated Water at Fukushima Daiichi NPPs, Viewing Both Offshore and Vapor Release Favorably
24 December, 2019
Fuel Removal from Fukushima Daiichi-1 NPP: Large Cover to be Installed First
18 December, 2019
JAEC Begins Hearing from University Personnel on Human Resource Development, Starting with Nagoya and Osaka Universities
13 December, 2019
NRA Approves Decommissioning Plans for Kansai EP’s Ohi-1 and-2
12 December, 2019
JAEA Holds International Forum on Peaceful Use of Nuclear Energy, Nuclear Non-Proliferation and Nuclear Security
29 November, 2019
NRA Issues Draft Review Report: Onagawa-2 Meets New Regulatory Standards
▲TOP